NO171592C - Fremgangsmaate for fremstilling av aktive cinnolin-derivater - Google Patents
Fremgangsmaate for fremstilling av aktive cinnolin-derivaterInfo
- Publication number
- NO171592C NO171592C NO862141A NO862141A NO171592C NO 171592 C NO171592 C NO 171592C NO 862141 A NO862141 A NO 862141A NO 862141 A NO862141 A NO 862141A NO 171592 C NO171592 C NO 171592C
- Authority
- NO
- Norway
- Prior art keywords
- cinnolin
- derivatives
- procedure
- active
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858513639A GB8513639D0 (en) | 1985-05-30 | 1985-05-30 | Cinnoline compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO862141L NO862141L (no) | 1986-12-01 |
| NO171592B NO171592B (no) | 1992-12-28 |
| NO171592C true NO171592C (no) | 1993-04-07 |
Family
ID=10579908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862141A NO171592C (no) | 1985-05-30 | 1986-05-29 | Fremgangsmaate for fremstilling av aktive cinnolin-derivater |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4886800A (es) |
| EP (1) | EP0205272B1 (es) |
| JP (1) | JPH0713062B2 (es) |
| KR (1) | KR900004402B1 (es) |
| CN (1) | CN1014060B (es) |
| AR (1) | AR242026A1 (es) |
| AT (1) | ATE66215T1 (es) |
| AU (1) | AU592086B2 (es) |
| CA (1) | CA1309406C (es) |
| DE (1) | DE3680828D1 (es) |
| DK (1) | DK162221C (es) |
| ES (3) | ES8801803A1 (es) |
| FI (1) | FI85584C (es) |
| GB (2) | GB8513639D0 (es) |
| GR (1) | GR861411B (es) |
| HU (1) | HU199433B (es) |
| IE (1) | IE58782B1 (es) |
| IL (1) | IL78992A0 (es) |
| MW (1) | MW4386A1 (es) |
| NO (1) | NO171592C (es) |
| PH (1) | PH23518A (es) |
| PL (1) | PL149227B1 (es) |
| PT (1) | PT82678B (es) |
| SU (1) | SU1500158A3 (es) |
| ZA (1) | ZA863664B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
| EP0328282B1 (en) * | 1988-02-09 | 1992-08-19 | Ici Americas Inc. | Pharmaceutical |
| US4925844A (en) * | 1988-02-09 | 1990-05-15 | Ici Americas Inc. | Antagonizing the pharmacological effects of a benzodiazepine receptor agonist |
| IL112235A (en) * | 1994-01-03 | 2000-06-29 | Acea Pharm Inc | 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them |
| DE60100999T2 (de) | 2000-03-21 | 2004-09-02 | Pharmacia & Upjohn Co., Kalamazoo | 4-oxo-1,4-dihydro-3-cinnolinecarbonsäure-amide als antivirusmittel |
| WO2001070742A1 (en) | 2000-03-21 | 2001-09-27 | Pharmacia & Upjohn Company | 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
| JP2003529601A (ja) | 2000-03-21 | 2003-10-07 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウイルス剤としての４−オキソ−１，４−ジヒドロ［１，８］ナフチリジン−３−カルボキサミド |
| BR0109391A (pt) | 2000-03-21 | 2003-06-03 | Upjohn Co | 4-hidroxicinolina-3-carboxiamidas como agentes antivirais |
| US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
| CA2634305A1 (en) * | 2005-12-20 | 2007-06-28 | Marc Chapdelaine | Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| AR067028A1 (es) * | 2007-06-19 | 2009-09-30 | Astrazeneca Ab | Compuestos y usos de los mismos 849 |
| WO2010123443A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate. |
| WO2010123441A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders |
| WO2010123440A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer |
| RU2017140639A (ru) * | 2011-05-23 | 2019-02-12 | Элан Фармасьютикалз, Инк. | Ингибиторы активности киназы lrrk2 |
| CN111905828B (zh) * | 2020-08-24 | 2022-04-19 | 万华化学集团股份有限公司 | 一种萘基配体mof活性炭复合催化剂及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657241A (en) * | 1970-03-12 | 1972-04-18 | Dow Chemical Co | Substituted cinnoline compounds |
| GB1306839A (en) * | 1970-10-16 | 1973-02-14 | Ici Ltd | Pharmaceutical compositions |
| GB1474399A (en) * | 1974-08-19 | 1977-05-25 | Ici Ltd | Cinnolin-3-yl carboxylic acids and derivatives thereof |
| US4085103A (en) * | 1974-11-07 | 1978-04-18 | Imperial Chemical Industries Limited | 6-Substituted-4-hydroxycinnolin-3-yl-carboxylic acids and esters thereof |
| GB1472766A (en) * | 1974-11-07 | 1977-05-04 | Ici Ltd | Hydroxycinnoline derivatives processes for their preparation and their use in pharmaceutical compositions |
| DD123525A1 (es) * | 1976-02-10 | 1977-01-05 | ||
| US4379929A (en) * | 1981-03-19 | 1983-04-12 | Eli Lilly And Company | 4(1H)-Oxocinnoline-3-carboxylic acid derivatives |
| US4729782A (en) * | 1983-09-14 | 1988-03-08 | Lafarge Coppee | Pollen suppressant comprising a fused pyridazinone |
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
-
1985
- 1985-05-30 GB GB858513639A patent/GB8513639D0/en active Pending
-
1986
- 1986-05-09 GB GB868611419A patent/GB8611419D0/en active Pending
- 1986-05-13 IE IE126786A patent/IE58782B1/en not_active IP Right Cessation
- 1986-05-16 ZA ZA863664A patent/ZA863664B/xx unknown
- 1986-05-20 PH PH33792A patent/PH23518A/en unknown
- 1986-05-22 AU AU57819/86A patent/AU592086B2/en not_active Ceased
- 1986-05-23 EP EP86303963A patent/EP0205272B1/en not_active Expired - Lifetime
- 1986-05-23 DE DE8686303963T patent/DE3680828D1/de not_active Expired - Lifetime
- 1986-05-23 AT AT86303963T patent/ATE66215T1/de not_active IP Right Cessation
- 1986-05-28 HU HU862243A patent/HU199433B/hu not_active IP Right Cessation
- 1986-05-29 CA CA000510335A patent/CA1309406C/en not_active Expired - Lifetime
- 1986-05-29 US US06/868,791 patent/US4886800A/en not_active Expired - Lifetime
- 1986-05-29 NO NO862141A patent/NO171592C/no unknown
- 1986-05-29 SU SU864027693A patent/SU1500158A3/ru active
- 1986-05-30 GR GR861411A patent/GR861411B/el unknown
- 1986-05-30 ES ES555546A patent/ES8801803A1/es not_active Expired
- 1986-05-30 FI FI862315A patent/FI85584C/fi not_active IP Right Cessation
- 1986-05-30 KR KR1019860004274A patent/KR900004402B1/ko not_active IP Right Cessation
- 1986-05-30 PL PL1986259791A patent/PL149227B1/pl unknown
- 1986-05-30 JP JP61123840A patent/JPH0713062B2/ja not_active Expired - Lifetime
- 1986-05-30 CN CN86104358A patent/CN1014060B/zh not_active Expired
- 1986-05-30 PT PT82678A patent/PT82678B/pt unknown
- 1986-05-30 DK DK256386A patent/DK162221C/da not_active IP Right Cessation
- 1986-05-30 AR AR86304166A patent/AR242026A1/es active
- 1986-05-30 MW MW43/86A patent/MW4386A1/xx unknown
- 1986-06-02 IL IL78992A patent/IL78992A0/xx not_active IP Right Cessation
-
1987
- 1987-04-30 ES ES557522A patent/ES8801903A1/es not_active Expired
- 1987-12-16 ES ES557790A patent/ES8802611A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
| NO163227C (no) | Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater. | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO864425L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater | |
| NO862651D0 (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
| NO862956D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
| NO865013D0 (no) | Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater. | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO169014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO864110L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater. | |
| NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
| NO163453C (no) | Fremgangsmaate for fremstilling av sphingosinderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO860429L (no) | Fremgangsmaate for fremstilling av imidazolyl-indol-derivater. | |
| NO865012D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
| NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO171108C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater | |
| NO842821L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater |